TAVR Update: Open vs. Closed Future Directions
|
|
- Annis Ramsey
- 5 years ago
- Views:
Transcription
1 TAVR Update: Open vs. Closed Future Directions Michael J. Reardon, M.D. Professor of Cardiothoracic Surgery Methodist DeBakey Heart & Vascular Center
2 Disclosures Advisory Board Medtronic Consultant Medtronic Corevalve trial Surgical local PI National steering committee National screening committee Publication committee SurTAVI trial National PI Steering committee Corevalve is not currently approved in the US
3 Access Routes Safe remote access to the aortic valve is imperative to success Transfemoral access is generally considered first if feasible If transfemoral is not feasible then options include; Subclavian Trans-apical Direct aortic
4 Considerations for Subclavian Access For 18 F sheath Corevalve Minimum 6 mm uncalcified or 7 mm calcified subclavian diameter Patent IMA bypass? Aortic angle Graft/ no graft?
5 Subclavian Access
6 Subclavian Access
7 2 year subclavian data Same survival as TF
8 Patent LIMA? Feasible and safe
9 Trans-apical Direct Aortic Most Direct Access for TAVR Neither limited by peripheral vascular status Neither limited by sheath size Neither limited by aortic angle Both avoid passing device across arch Both allow precise deployment due to proximity
10 Direct Aortic Access Can be done without a thoracotomy less pulmonary impairment Requires no injury to the myocardium Aorta moves much less than cardiac apex Bleeding around the sheath not a problem Can be used for Corevalve or Sapien Can replace ascending aorta All surgeons cannulate the aorta
11
12 Mini AVR Mini Sternotomy Mini thoracotomy
13 Mini Arch Hybrid Approach
14 Mini thoracotomy 2 patients done via small right anterior thoracotomy 2010
15 Mini Thoracotomy 6 patients done via small right anterior thoracotomy with 1 death 2011
16 Mini-Sternotomy patients with transaortic implant via upper hemi sternotomy
17 Direct Aortic Access Approaches Sternotomy Upper Mini Sternotomy Thoracotomy Port Access? Incision Location Sternotomy Upper Stern. Thoracotomy Port Incision Size 12+ cm 5+ cm 4-5 cm - - Visualization Direct Direct Direct Indirect
18 Thoracotomy or Sternotomy? What is behind the sternum?
19 Workflow CT DynaCT Valve Deployment Aortic Root Segmentation from CT & Planning for DA access Non-contrast DynaCT acquired & registered to DynaCT Overlay of landmarks from CT onto live fluoroscopy image
20 Planned Aortic Puncture area 6.8 cm Annulus Plane
21
22 Mini J Upper Sternotomy 6 cm incision Right 3 rd ICS Sternal notch down
23
24
25
26
27 Mini Sternotomy DA Access
28 11
29 Mini Thoracotomy DA Access
30
31 Direct Aortic and Subclavian Aceess will represent about 20% of the Corevalve trial No results will be released until the closure and publication of the trial 2013!
32 European experience of Direct Aortic TAVI with a Self-Expanding Prothesis Neil Moat 1, Hasan Bushnaq 2, Marjan Jahangiri 3, Domenico Mazitelli 4 Hafid Amrane 5, Marian Branny 6, Johan Bosmans 7, Mo Bhabra 8, Peter den Heijer 9, Uday Trivedi 10, Didier Tchetche 11, Rudiger Lange 4, Jean-Claude Laborde 3 and Giuseppe Bruschi 12 1 Royal Brompton, London UK; 2 Martin-Luther-University, Halle an der Saale, Germany; 3 St Georges Hospital, London, UK; 4 German Heart Centre Munich, Munich Germany; 5 Medisch Centrum Leeuwarden; 6 Hospital Podlesi, Czech Republic; 7 Antwerp University Hospital, Antwerp Belgium; 8 University of Birmingham, London UK; 9 Amphia Hospital Breda, Breda, The Netherlands; 10 Brighton and Sussex University Hospitals, Brighton UK; 11 Clinique Pasteur, Toulouse, France, 12 Niguarda Ca Granda Hospital, Milan, Italy Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
33 Centre Clinicians Cases; N=93 Niguarda Ca Granda, Milan, Italy Bruschi, Klugmann 23 Royal Brompton Hospital, London, UK Moat, Davies 13 Universitätsklinikum Halle, Germany Bushnaq, Ebelt 10 St Georges, London, UK Jahangiri, Brecker 9 German Heart Centre, Munich Mazzitelli,Lange 8 Medisch Centrum Leeuwarden, NL Amrane, van Boven 6 Hospital Podlesi, Czech Republic Branny, Branny 5 New Cross Hosp, Wolverhampton, UK Bhabra, Khogali 4 Antwerp University Hospital, Belgium Bosmans, Rodrigues 4 Amphia Ziekenhuis, Breda, NL Den Heijer, Bentala 4 Royal Sussex Hosp, Brighton, UK Trivedi, Hildick-Smith 4 Clinique Pasteur, Toulouse, Fr Tchetche, Garcia 3 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
34 Procedural Data Minithoracotomy 49/93 (52.5%) Ministernotomy 44/93 (47.5%) Procedural success 92/93 (98.9%) Valve Size 26mm 36/92 (39.1%) Valve Size 29mm 50/92 (54.3%) Valve Size 31mm 6/92 (6.6%) Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
35 30 day Mortality 9/93 (9.7%) In-hospital Stroke 3/93 (3.2%) Thoracic Aortic Dissection 0/93 (0%) Life Threatening Bleed (VARC) 4/93 (4.3%) Major Vascular Injury (VARC) 4/93 (4.3%) Conversion to Full Sternotomy 4/93 (4.3%) New Permanent Pacemaker 16/93 (17.2%) Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
36 Results 93 patients underwent TAVI with the Medtronic CoreValve TM via Direct Aortic Access between 6 June 2008 and 31 December 2011 (the FIM experience with any DAA TAVI was in Munich and at the Brompton between June November 2008) 20 (21.6%) implants took place in the 54 months between the first implant and 1/1/11 73/93 (78.4%) of implants took place in the last calender year (1/1/ /12/2011)
37 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
38 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
39 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
40 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
41 Presented at the 48 th meeting of the STS, Fort Lauderdale, Florida, January 2012.
42 Direct Aortic Can be done without a thoracotomy less pulmonary impairment Requires no injury to the myocardium Aorta moves much less than cardiac apex Bleeding around the sheath not a problem Aortic cannulation (sheath) more familiar to most cardiac surgeons Can be used for Corevalve or Sapien Sheath size does not matter Direct aortic access is growing rapidly and may largely replace trans-apical
43 Mini J Upper Sternotomy Advantages Fits more anatomies More Real Estate to choose from Axiality can be more difficult Do not enter pleural Initially feels safer to many surgeons Quick and easy in virgin chest
44 Thoracotomy Advantages Safer in redo chest Generally more axial Disadvantages Generally less more to work Pleura crossed
45 Take Home Message DA Access is safe and effective 3D Image Guidance & Planning using CTA & NON-Contrast DynaCT with alignment based on the calcification of the Aorta and AV can help guide puncture and procedure Both thoracotomy and sternotomy work but carry different pros and cons
46 Trans-apical Courtesy Anson Cheung MD
47 Conclusion Transfemoral, Transaxillary, and Transaortic, Transapical The best option is the one that minimizes the risk of the procedure and offers the best result for the patient. The best decision come from a true Heart Team
48 Thank You
Which One is Better? CoreValve is Better!
TCT Asia-Pacific Seoul, April 26th, Korea Which One is Better? CoreValve is Better! Eberhard Grube MD, FACC, FSCAI Universitätsklinikum Bonn, Bonn, Germany Hospital Alemão Oswaldo Cruz, São Paulo, Brazil
More informationTAVI Summit Eberhard Grube MD FACC, FSCAI Universitätsklinik Bonn, Medizinische Klinik und Poliklinik II, Bonn, Germany
TAVI Summit 2012 Seoul, September 8, 2012 TAVI Various Access Sites Eberhard Grube MD FACC, FSCAI Universitätsklinik Bonn, Medizinische Klinik und Poliklinik II, Bonn, Germany StanfordUniversity University,
More informationThe Medtronic Core Valve System Direct Aortic Approch
3 rd TAVI Summit Seoul, August 9/10, 2013 The Medtronic Core Valve System Direct Aortic Approch Eberhard Grube MD, FACC, FSCAI Michael Reardon MD Michael Reardon MD Michael J. Reardon, M.D. Senior Member
More informationDr. Jean-Claude Laborde
Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,
More informationAlternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy
Alternate Vascular Access for TAVR Gian Paolo Ussia Campus Bio-medico University, Rome Italy g.ussia@unicampus.it REQUIRED Gian Paolo Ussia I have no relevant financial relationships Transcatheter Valves
More informationTranscatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40
Transcatheter Aortic Valve Implantation SSVQ November 23, 2012 Centre Mont-Royal 15:40 Nicolo Piazza MD, PhD, FRCPC, FESC, FACC McGill University Health Center German Heart Center Munich 1 First-in-Human
More informationTAVR Transaortic Approach: New Trends in Aortic Valve Surgery
: New Trends in Aortic Valve Surgery Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Director, Center for Diseases of the Thoracic Aorta Washington University School of
More informationPercutaneous Transapical Access for Thoracic Endovascular Repair
Percutaneous Transapical Access for Thoracic Endovascular Repair Atman P. Shah MD FACC FSCAI Co-Director, Hans Hecht Cardiac Catheterization Laboratory Clinical Director, Section of Cardiology Associate
More informationEdwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved
Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio
More informationIgor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School
Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of
More informationDavid Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS. Peripheral Complications of TAVR
David Dexter MD FACS Sentara Vascular Specialists Assistant Professor of Surgery EVMS Peripheral Complications of TAVR TAVR Complications Reported Complications Rates range from 8% to 15% Predictors of
More informationTAVR in Intermediate Risk Populations /Optimizing Systems for TAVR
TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR Saibal Kar, MD, FACC, FAHA, FSCAI Professor of Medicine Director of Interventional Cardiac Research Smidt Heart Institute, Cedars-Sinai
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More information22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.
Oxford City Transcatheter aortic valve replacement 2017 guidelines Monday 19 th June Jim Newton Oxford Oxford University Hospitals NHS FT How familiar are you with TAVR? 1. First time I have heard about
More informationImage Assistance in TAVI Why CT? Won-Jang Kim, MD, PhD Clinical Assistant Professor of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea
Image Assistance in TAVI Why CT? Won-Jang Kim, MD, PhD Clinical Assistant Professor of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea Major Uses of CT in TAVI Ileofemoral Patient Arterial
More informationDevelopments in Valve Surgery
Developments in Valve Surgery Introduction Will discuss Aortic Valve and Mitral Valve surgery What is a mini valve operation? When do we do traditional valve surgery (SAVR, SMVR) vs. mini valve surgery
More informationAfter PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?
After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial
More informationPrevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation
Prevention and Management of Vascular Complications Related to Transcatheter Aortic Valve Implantation Marco Roffi Division of Cardiology University Hospital Geneva, Switzerland Disclosure Speaker name:...marco
More informationAortic valve implantation using the femoral and apical access: a single center experience.
Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany
More information30-day Outcomes of The CENTERA Trial a New Self-Expanding Transcatheter Heart Valve. Didier Tchétché, MD On Behalf of the CENTERA Investigators
30-day Outcomes of The CENTERA Trial a New Self-Expanding Transcatheter Heart Valve Didier Tchétché, MD On Behalf of the CENTERA Investigators Speaker's name: Didier Tchétché, MD I have the following potential
More informationMINIMALLY INVASIVE AVR
MINIMALLY INVASIVE AVR MATTHEW S. PANAGIOTOU MD FETCS CARDIAC SURGEON MEDITERRANEAO HOSPITAL MINIMALLY INVASIVE AVR In cardiac surgery Minimally invasive has been defined as a small chest incision that
More informationAortic Valve Stenosis and TAVR: Putting it all together.
Aortic Valve Stenosis and TAVR: Putting it all together. Maria L. Held, MSN CNS Valve Clinic Coordinator at The Cleveland Clinic Alliance of Cardiovascular Professionals April 14 th, 2018 Brief Anatomy
More informationTranscatheter Aortic Valve Implantation (TAVI)
Transcatheter Aortic Valve Implantation (TAVI) QEH Registry A Multidisciplinary Team Approach Michael KY Lee 1, LK Chan 1, KC Chan 1, KT Chan 1, SF Chui 1, HS Ma 1, CY Wong 1, CS Chiang 1, P Li 1, CB Lam
More informationIs TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?
Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients? Didier TCHETCHE, MD. Clinique PASTEUR, Toulouse, France, Conflicts of interest: -Consultant for Edwards LifeSciences
More informationNew Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology
New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.
More informationAVR with Sutureless Valves State of the Art
AVR with Sutureless Valves State of the Art T. Fischlein Department of Cardiac Surgery, Cardiovascular Center Klinikum Nürnberg Paracelsus Medical University Nuremberg, Germany Disclosures Consultant and
More informationTAVR for low-risk patients in 2017: not so fast.
TAVR for low-risk patients in 2017: not so fast. Enrico Ferrari, MD, FETCS Cardiac Surgery Department Cardiocentro Ticino Foundation Lugano, Switzerland Conflicts of Interest Consultant and proctor for
More informationTAVI complication. Possible aetiology and how to manage
TAVI complication. Possible aetiology and how to manage Dr Sanjeevan Pasupati Waikato Hospital, Hamilton, New Zealand Operators: Dr Sanjeevan Pasupati, Mr Nand Kejriwal, Mr Adam Elgamel Valve Positioning
More informationTranscatheter Aortic Valve Implantation Present Status and Perspectives
Transcatheter Aortic Valve Implantation Present Status and Perspectives Angioplasty Summit TCTAP 2010 Alain Cribier, MD University of Rouen, France Transcatheter Aortic Valve Implantation has entered the
More informationResults of Transapical Valves. A.P. Kappetein Dept Cardio-thoracic surgery
Results of Transapical Valves A.P. Kappetein Dept Cardio-thoracic surgery Rotterda am, The Netherlands 2002 FIM 2003 2005 2006 2010 THV THV Cribier-Edwards Edwards Edwards Sapien Sapien XT Bovine pericardium
More informationTranscatheter Valve Replacement: Current State in 2017
Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP
More informationPolicy Specific Section: March 30, 2012 March 7, 2013
Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:
More information3 years after introduction of TAVI in QEH. Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong
3 years after introduction of TAVI in QEH Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong HA Convention 2014 Introduction Aortic Stenosis most common valvular heart disease
More informationTAVR and Cardiac Surgeons
TAVR and Cardiac Surgeons TAVR and Cardiac Surgeons Ragheb Hasan Consultant and Clinical Lead Cardiothoracic Surgeon Manchester Royal Infirmary, Oxford Road, Manchester UK Aortic Stenosis Is A Growing
More informationTAVI: Nouveaux Horizons
TAVI: Nouveaux Horizons EUAPI580i 432HQ14NP02353 Institut de Cardiologie de la Pitié-Salpêtrière jean-philippe.collet@psl.aphp.fr www.action-coeur.org Objectifs Les recommandations Le TAVI en chiffre La
More informationValve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.
Valve Surgery Total Volume 1 1 Volume 35 3 5 15 1 5 1 13 1 N = 773 5 79 15 93 1 339 In 1, surgeons performed 339 valve surgeries. surgeons have implanted more than 1, bioprosthetic aortic valves since
More informationAortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?
Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV? Samin K Sharma, MD, FACC, FSCAI Director Clinical & Interventional
More informationTAVR alternative access: Transapical, transaortic, transubclavian, suprasternal, transcarotid For whom and how
TAVR alternative access: Transapical, transaortic, transubclavian, suprasternal, transcarotid For whom and how Lozos Vasileios, MD, FECTS, MSc, Clinical Consultant Cardiothoracic Clinic of Kapodistrian
More informationThe Heart Team 8/6/2013. Can Cardiologist and CV Surgeons really work together? Disclosures OWNERSHIP/EQUITY:
8/6/2013 The Heart Team Michael J Mack MD David L Brown MD The Heart Hospital Baylor Plano Can Cardiologist and CV Surgeons really work together? David Brown Disclosures OWNERSHIP/EQUITY: The Heart Hospital
More informationTranscatheter Aortic Valve Replacement TAVR
Transcatheter Aortic Valve Replacement TAVR Paul Gordon, MD Associate Prof of Medicine, Brown University Director, Cardiac Catheterization Laboratory The Miriam Hospital Disclosures: none 100 Symptomatic
More informationEndovascular treatment of aortic arch using Relay branched stent grafts
Endovascular treatment of aortic arch using Relay branched stent grafts B. Saint-Lèbes Vascular surgery unit Rangueil Universitary hospital Toulouse France Disclosure of Interest Speaker name: SAINT-LEBES
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationTranscatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data
Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,
More informationTranscatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital,
Transcatheter aortic valves in aortic regurgitation Gry Dahle Dept of Cardiothoracic- and vascular surgery Rikshospitalet, Oslo University Hospital, Oslo, Norway Aortic regurgitation Prevalence in Framingham
More informationTranscatheter aortic valve implantation and pre-procedural risk assesment
Transcatheter aortic valve implantation and pre-procedural risk assesment Alec Vahanian,FESC, FRCP(Edin.) Bichat Hospital University Paris VII, Paris, France Disclosures Relationship with companies who
More informationTAVI: Transapical Procedures
Cardiology Update Davos TAVI: Transapical Procedures Volkmar Falk, MD University Hospital Zürich TA-AVI: antegrade, simple, safe The front door approach! Transapical TAVI Technical advantages of TA approach
More informationAntegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation
Antegrade Thoracic Stent Grafting during Repair of Acute Debakey I Dissection: Promotes Distal Aortic Remodeling and Reduces Late Open Re-operation Vallabhajosyula, P: Szeto, W; Desai, N; Pulsipher, A;
More informationVascular complications of embolized core valve
Vascular complications of embolized core valve Suhail Dohad, MD FACC Director of Endovascular services, Interventional Cardiology Cardiovascular Research Foundation of Southern California, CVMG Director
More informationAppropriate Use of TAVR - now and in the future. A Surgeon s Perspective. Neil Moat Royal Brompton Hospital, London, UK
Appropriate Use of TAVR - now and in the future A Surgeon s Perspective Neil Moat Royal Brompton Hospital, London, UK Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner
More informationEvolving and Expanding Indications for TAVR
Evolving and Expanding Indications for TAVR Wilson Y. Szeto, MD Associate Professor of Surgery Surgical Director, Transcatheter Cardio-Aortic Therapies Associate Director, Thoracic Aortic Surgery Division
More information2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route
Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National
More informationTRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH
TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.
More informationTAVI EN INSUFICIENCIA AORTICA
TAVI EN INSUFICIENCIA AORTICA Cesar Moris Profesor Cardiología Director Departamento del Corazón Hospital Universitario Central de Asturias Universidad de Oviedo OVIEDO -- ESPAÑA CONFLICTO DE INTERESES
More information7 th Conference of Transcatheter Heart Valve Therapies
7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis
More informationDr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong
Dr Winnie Sze-Wun Chan Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong Why? Is CT reliable? How to perform the CT study? How to interpret the CT study?
More informationIncorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)
Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine
More informationEndovascular Ascending Repair: Is This the Next Frontier?
Endovascular Ascending Repair: Is This the Next Frontier? The 11 th Houston Aortic Symposium Session II: Ascending Aorta/Aortic Dissection (Proximal) February 15, 2018 Michael D. Dake, M.D. Thelma and
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationTAVR: Echo Measurements Pre, Post And Intra Procedure
2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate
More informationTAVR Where are We Going? Victor Guetta, MD FESC FACC The Chaim Sheba Medical Center
TAVR 2013 - Where are We Going? Victor Guetta, MD FESC FACC The Chaim Sheba Medical Center Disclosures I have the following financial relationships to disclose: Edwards Boston Scientific Type of relation:
More informationOptimal Imaging Technique Prior to TAVI -Echocardiography-
2014 KSC meeting Optimal Imaging Technique Prior to TAVI -Echocardiography- Geu-Ru Hong, M.D. Ph D Associate Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University
More informationMinimally invasive left ventricular assist device placement
Original Article on Cardiac Surgery Minimally invasive left ventricular assist device placement Allen Cheng Department of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, USA
More informationTAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology
TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for
More informationLess Invasive Reoperations for Aortic and Mitral Valve Disease. Peter Bent Brigham Hospital 1913
Shapiro CV Center 2008 Peter Bent Brigham Hospital 1913 Lawrence H. Cohn, MD, Professor of Cardiac Surgery, HMS Division of Cardiac Surgery, BWH, Boston, MA 70% of US valve patients select bioprosthetic
More informationEarly Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study
Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have
More informationDisclosures. During the past 12 months, I have received research grants, advisory boards, consultation fees/honoraria, and/or travel expenses from:
Update on Transcatheter Aortic Valve Replacement Vinod H. Thourani, MD Associate Professor of Cardiothoracic Surgery Associate Director, Structural Heart Center Associate Director, CTS Clinical Research
More informationTranscatheter Aortic Valve Implantation (TAVI) Overview for Wales. Dr Richard Anderson University Hospital of Wales, Cardiff, UK
Transcatheter Aortic Valve Implantation (TAVI) Overview for Wales Dr Richard Anderson University Hospital of Wales, Cardiff, UK Aortic stenosis is a disease of old age Age demographics in Wales % Wales
More informationThe Transaortic Approach for Transcatheter Aortic Valve Replacement Initial Clinical Experience in the United States
Journal of the American College of Cardiology Vol. 61, No. 23, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.02.076
More informationTranscatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee
Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Queen Elizabeth Hospital, Hong Kong President, HKSTENT APCASH 2013 SJ Park TAVI Summit 2013
More informationJean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,
More informationMasterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach
Masterclass III Advances in cardiac intervention Percutaneous valvular intervention a novel approach Professor Roger Boyle CBE National Director for Heart Disease and Stroke London Medical therapy Medical
More informationOutcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison
Outcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison Mauri, V. et al.: Circ Cardiovasc Interv. 2017;10:e005013 All trademarks are the property
More informationProf. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation
Prof. Dr. Thomas Walther TAVI in ascending aorta / aortic root dilatation nn AorticStenosis - Guidelines TAVI and aortic aneurysm? Few data published. EJCTS 2014;46:228-33 TAVI and aortic aneurysm? Few
More informationIf left untreated, mortality for symptomatic aortic
Alternative Access Routes for TAVR The feasibility, safety, and efficacy of transcatheter aortic valve replacement from the several possible access sites available. By Hunaid A. Vohra, FRCS (CTh); Rizwan
More informationTranscatheter Aortic Valve Replacement (TAVR)
UW MEDICINE PATIENT EDUCATION Transcatheter Aortic Valve Replacement (TAVR) Treatment for aortic stenosis This handout explains when your doctor may advise TAVR to treat aortic stenosis. It includes the
More information2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR
TRANSCATHETER AORTIC VALVE REPLACEMENT IN 2018: IS IT NOW THE STANDARD OF CARE? 22 ND ANNUAL COASTAL CARDIAC & VASCULAR CONFERENCE FEBRUARY 17, 2018 R. David Anderson, MD, MS, FACC, FSCAI Professor of
More informationAortic Stenosis Background and Breakthroughs in Treatment: TAVR Update
Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update Howard J Broder MD Interventional Cardiology DaVita Medical Group/ Healthcare Partners Cardiology Disclosures for Howard J Broder
More information1-YEAR OUTCOMES FROM JOHN WEBB, MD
1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following
More informationValve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.
Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D. Professor, Thoracic and Cardiovascular Surgery University of Florida klodell@surgery.ufl.edu Disclosures
More informationPeri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)
Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY) Thomas Walther, Christian W. Hamm, Gerhard Schuler, Alexander Berkowitsch,
More informationNational Institute for Health and Care Excellence IP865/2 Sutureless Aortic Valve Replacement for aortic stenosis
National Institute for Health and Care Excellence IP865/2 Sutureless Aortic Valve Replacement for aortic stenosis IPAC 14/06/18: 1 1 NHS professional 2 1 NHS professional ments 1.1 1.1 Current evidence
More informationOptimal Techniques for Obtaining Large Caliber Arterial Access
Optimal Techniques for Obtaining Large Caliber Arterial Access Gerald Yong MBBS (Hons) FRACP FSCAI Interventional Cardiologist Royal Perth Hospital Western Australia APCASH 11 October 2014 Disclosure Statement
More informationThe Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy
The Future of Medicine Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy FIRST PATIENT TO UNDERGO PTCA FIRST PATIENT TO UNDERGO TAVI Grüntzig
More informationTranscatheter aortic valve implantation (TAVI): an example of how to organise a TAVI programme
original article Transcatheter aortic valve implantation (TAVI): an example of how to organise a TAVI programme J M ten Berg R Heijmen As the population ages, aortic valve stenosis becomes more prevalent.
More informationTranscatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis
More informationSentinel Dual Filter Device: Technology Overview and Status of the CLEAN-TAVI Randomized Trial. Martin B. Leon, MD
8 mins Sentinel Dual Filter Device: Technology Overview and Status of the CLEAN-TAVI Randomized Trial Martin B. Leon, MD Columbia University Medical Center Cardiovascular Research Foundation New York City
More informationThe Role of TAVI in high-risk and normal-risk Patients
The Role of TAVI in high-risk and normal-risk Patients Joachim Schofer Hamburg University Cardiovascular Center and Department for percutaneous treatment of structural heart disease Albertinen Heart Center
More informationTranscatheter Aortic Valve Replacement with Evolut-R
Transcatheter Aortic Valve Replacement with Evolut-R Department of Transcatheter Heart Valves and 2 nd Cardiothoracic Surgery Clinic K. Spargias, M.Chrissoheris, A.Halapas, I. Nikolaou, S.Pattakos Disclosures
More informationManagement of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria
Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type
More informationAortic Stenosis: Open vs TAVR vs Nothing
Aortic Stenosis: Open vs TAVR vs Nothing Wilson Y. Szeto, MD Associate Professor of Surgery Surgical Director, Transcatheter Cardio-Aortic Therapies Associate Director, Thoracic Aortic Surgery Division
More informationAn Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.
An Update on the Edwards TAVR Results Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St. Luke s Hospital Disclosures On the speaker s bureau for Endologix, TriVascular,
More informationTranscatheter Aortic Valve Implantation Using CoreValve by Transaortic Approach
Case Report http://dx.doi.org/10.12997/jla.2013.2.2.85 pissn 2287-2892 eissn 2288-2561 JLA Transcatheter Aortic Valve Implantation Using CoreValve by Transaortic Approach Kyeong-Hyeon Chun 1, Young-Guk
More informationHardware in the Chest - From VADs to Valves
Hardware in the Chest - From VADs to Valves Cristina Fuss, MD Purpose Recognize the device Indication and function Cristina Fuss, MD Department of Diagnostic Radiology FROM VADS TO VALVES Implanting technique
More informationValve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.
Valve Surgery 11 15 Volume 3 1 11 1 13 1 N = 1 773 5 79 15 93 In 15, surgeons performed 93 valve surgeries. surgeons have implanted more than 1,5 bioprosthetic aortic valves since the 199s, with excellent
More informationTAVR Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory. Cleveland Clinic.
TAVR 2015 Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Outline Aortic Stenosis TAVR Who should be considered for TAVR What are the treatment options? Valves, Approaches
More informationDebate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI
Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI Joseph E. Bavaria, MD Roberts-Measey Professor of Surgery Vice Chair, Division of Cardiovascular Surgery University of Pennsylvania Immediate
More informationFor the SURTAVI Investigators
Neurological complications after transcatheter aortic valve implantation with a self-expanding bioprosthesis or surgical aortic valve replacement in patients at intermediate-risk for surgery A. Pieter
More informationImaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013
Imaging in TAVI Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston Scientific, St Jude, BMS imaging, GE Healthcare,
More informationCORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST
CORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST I have constructed this lecture based on publications by leading cardiothoracic American surgeons: Timothy
More informationMinimally Invasive Aortic Arch Surgery:
Minimally Invasive Aortic Arch Surgery: Where are we? Where are we headed? Jehangir J. Appoo Libin Cardiovascular Institute University of Calgary www.aorta.ca June 15, 2016 Cardiac Masters Day: Minimally
More information